Functional dyspepsia: bye-bye to PPIs.
Nyrén
O
O
Department of Medical Epidemiology, Karolinska Institutet, Box 281, S-171 77 Stockholm, Sweden. olof.nyren@mep.ki.se
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D004415:Dyspepsia / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D005764:Gastroesophageal Reflux / Q000150:complications / Q000453:epidemiology; D016481:Helicobacter Infections / Q000150:complications; D016480:Helicobacter pylori; D006801:Humans; D064747:Lansoprazole; D009853:Omeprazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D054328:Proton Pump Inhibitors
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D009853:Omeprazole